期刊文献+

高海拔地区藏族和汉族乳腺浸润性导管癌凋亡相关蛋白及凋亡指数的研究 被引量:1

Comparison of apoptosis-related proteins and apoptosis index of breast invasive ductal cancers between Tibetan and ethnic Han in high altitude
下载PDF
导出
摘要 目的探讨世居青海的藏汉族人乳腺浸润性导管癌组织中Bcl-2、Bax及Caspase-3和凋亡指数(AI)的表达差异。方法采用免疫组织化学法检测藏族和汉族各60例乳腺浸润性导管癌中Bcl-2、Bax及Caspase-3蛋白的表达;采用原位DNA缺口末端标记法检测凋亡指数。结果藏族、汉族乳腺浸润性导管癌组织中Bcl-2的表达率分别为52.2%和38.3%,Bax表达率分别为76.7%和61.7%,Caspase-3表达率分别为60.0%和58.3%,藏族、汉族乳腺浸润性导管癌组织中AI阳性率分别为61.2%和60.0%,差异均无统计学意义(P>0.05)。结论世居青海的藏族和汉族乳腺浸润性导管癌组织中Bcl-2、Bax及Caspase-3的表达无差异,且乳腺浸润性导管癌组织中AI表达比较也无差异。 Objective To investigate the expressions of Bcl-2, Bax, Caspase-3 and apoptotic index (AI) in breast invasive ductal cancer between different ethnic groups, and to analyze their correlations with clinicopathological characteristics. Methods The expressions of Bcl-2, Bax and caspase-3 in breast invasive ductal cancers of 60 cases each of Tibetan and ethnic Han were examined with immunohistochemical stain in histopathologic slides. AI was detected by TUNEL method. Results The positive expression rates of Bcl-2 in breast invasive ductal cancer of Tibetan and ethnic Han were 52.2% and 38.3% respectively (P > 0.05);the positive expression rates of Bax were 76.7% and 61.7% respectively (P > 0.05);the positive expression rates of Caspase-3 were 60.0% and 58.3% respectively (P > 0.05);the AI was 61.2% and 60% respectively (P > 0.05). Conclusions The positive expression rates of Bcl-2, Bax and caspase-3 of breast invasive ductal cancers between Tibetan and ethnic Han demonstrate no statistically difference, and AI didn’t show any difference either.
作者 杨娟 李亚飞 宋晓燕 袁青玲 祁玉娟 Juan Yang;Ya-fei Li;Xiao-yan Song;Qing-ling Yuan;Yu-juan Qi(Qinghai Provincial People’s Hospital,Xining,Qinghai 810007,China)
机构地区 青海省人民医院
出处 《中国现代医学杂志》 CAS 2019年第14期24-30,共7页 China Journal of Modern Medicine
基金 青海省自然科学基金青年项目(No:2012-Z-940Q)
关键词 乳腺肿瘤 原癌基因蛋白质Bcl-2 凋亡抑制蛋白质类 生物多样性 breast neoplasms genes, bcl-2 apoptosis regulatory proteins, inhibiting biodiversity
  • 相关文献

参考文献3

二级参考文献24

  • 1付强,于世英,许三鹏.乳腺癌HER2过度表达预后相关因素研究[J].肿瘤防治研究,2008,35(S1):9-11. 被引量:8
  • 2李艳萍,张斌,喻卫红,吕大鹏,郭怡辉,高宏.Bcl-2、C-erbB2和PCNA表达与乳腺癌新辅助治疗疗效关系的研究[J].中国肿瘤临床与康复,2007,14(1):8-10. 被引量:6
  • 3杨黎,朱霞,冉立.HER-2、PCNA、Bcl-2、Bax在乳腺癌组织中的表达与预后的关系[J].癌症,2007,26(7):756-761. 被引量:17
  • 4Cheng EH, Kirseh DG, Clem RJ, et al. Conversion of Bcl - 2 to a bax - like death effector by caspases [ J ]. Science, 1997, 278 : 1966 - 1968. 被引量:1
  • 5Voutsadakis IA. Apoptosis and the pathogenesis of lymphoma[J]. Acta Oncol, 2000,39 : 151 - 156. 被引量:1
  • 6Fernandez - Ainem Lri T, Litwaek G, Alnemri Es. ecp32, a novel human apotosis protein with homology to caehorhabditis elegans cell death protein eed - 3 and mammalian inerlenkin - 1 beta - converting enzyme [ J ]. Biol Chem, 1994, 269 ( 49 ) : 30761--30767. 被引量:1
  • 7Winter RN, Kramer A, Borkowaki A, et al. Lose of capase - 1 and capase -3 protein expression in human prostate cancer[ J]. Cancer Res,2001, 61(3) : 1227 -1232. 被引量:1
  • 8Hoshi T, Sasano H, Kato K, et al. Immunohistochemistry of caspase3/CPP32 in human stomach cancer and its correlation with cell proliferation and apoptosis [ J ]. Anticancer Res, 1998, 18 : 4347 - 4353. 被引量:1
  • 9WolffAC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer[J]. J Clin Oncol, 2007,25(1) : 118. 被引量:1
  • 10Hussein MR, Abd-Elwahed SR, Abdulwahed AR. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcino-as of the breast[J]. Cell Biol lnt, 2008,32 (6) : 698. 被引量:1

共引文献19

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部